I was there, it was pretty much what you can read from today's announcements. Sounds like the next major ann will be lumbar results. Dr Weiner told us about himself over the phone from isreal. The endpoints for CHF ph3 will be the same as those met in ph2, just a much larger trial. They want the one ph3 trial to satisfy the fda and european regulators. I had to leave prior to question time unfortunately.. gg
agm thoughts/feedback appreciated, page-3
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |